{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:04:33Z","timestamp":1793210673109,"version":"4.5.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer-related lymphedema (BCRL) is a common and life-long adverse event affecting ~20% of breast cancer survivors. As existing non-pharmacologic management is burdensome, expensive, and variably effective, this systematic scoping review aims to identify pharmacologic and herbal agents for prevention and treatment for BCRL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMED, Embase, Web of Science Core collection, and the Cumulative Index to Nursing and Allied Health Literature were searched for studies published in English between 1993 and 2025 that investigated the preventative or therapeutic effect of pharmacologic or herbal agents on BCRL among adult stage I-III breast cancer patients. Studies describing interventions with systemically absorbed anti-inflammatories, anti-thrombotics, anti-coagulants, and blood product components were included. Systematic reviews, protocols for ongoing clinical trials, preclinical and non-human studies, editorials, and studies not exclusive to BCRL were excluded. Three reviewers screened and extracted data between June and August 2025. The primary outcomes of interest were reduction in BCRL incidence or severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 217 articles screened, 37 were included in the final review. After full text review, 13 were excluded for repetitive data, non-English language, or irrelevant outcomes. The 24 studies included in the analysis investigated anti-diabetic, herbal, anti-inflammatory, anti-hypertensive, immunomodulatory, and microbiome modifying agents, and venoactive flavinoid derivates. Three studies explored the role of pharmacologic\/herbal agents in BCRL prevention. While thiazolidinediones, anti-hypertensives, and non-steroidal anti-inflammatory drugs (NSAIDs) had no effect on BCRL incidence, glucagon-like peptide-1 receptor agonists (GLP-1 RA) were associated with BCRL prevention. In the 21 studies that assessed the effect of pharmacologic\/herbal agents in BCRL treatment, NSAIDs\/steroids, anti-hypertensives, microbiome\/synbiotic supplements, and doxycycline showed no benefit and data for flavonoid-derived venoactive agents and herbal products were inconsistent. Immune-modulating therapies were associated with improved BCRL signs\/symptoms in three studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This systematic scoping review found limited evidence suggesting that GLP-1 RAs may reduce the risk of BCRL and that immunomodulatory agents may improve signs\/symptoms of BCRL. Rigorous prospective trials using standardized limb volume\/edema, quality-of-life (QoL), and symptom measures and longer follow-up are needed to inform clinical practice aimed at preventing and treating BCRL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD420251055134.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1751628","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:40:47Z","timestamp":1772602847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review"],"prefix":"10.3389","volume":"16","author":[{"given":"Caroline","family":"Lommer","sequence":"first","affiliation":[{"name":"The Ohio State University College of Medicine","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital","place":["Columbus, OH, United States"]},{"name":"The Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), College of Medicine, The Ohio State University","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Amato","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital","place":["Columbus, OH, United States"]},{"name":"The Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), College of Medicine, The Ohio State University","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dhakal","sequence":"additional","affiliation":[{"name":"Health Sciences Library, The Ohio State University","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Kotian","sequence":"additional","affiliation":[{"name":"Oncology Rehabilitation, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionisia","family":"Quiroga","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center and James Cancer Hospital","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electra D.","family":"Paskett","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital","place":["Columbus, OH, United States"]},{"name":"The Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), College of Medicine, The Ohio State University","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei R.","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Nursing and Health Studies, University of Missouri-Kansas City","place":["Kansas, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Scheck","family":"McAlearney","sequence":"additional","affiliation":[{"name":"The Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), College of Medicine, The Ohio State University","place":["Columbus, OH, United States"]},{"name":"Comprehensive Cancer Center, The Ohio State University","place":["Columbus, OH, United States"]},{"name":"Department of Family and Community Medicine, College of Medicine, The Ohio State University","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Collins","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, The Ohio State University","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, Department of Surgery, Emory University School of Medicine","place":["Atlanta, GA, United States"]},{"name":"Winship\u2019s Glenn Family Breast Center, Winship Cancer Institute of Emory University","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Mayo Clinic","place":["Jacksonville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara P.","family":"Myers","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital","place":["Columbus, OH, United States"]},{"name":"The Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), College of Medicine, The Ohio State University","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235998","article-title":"Do patient-reported upper-body symptoms predict breast cancer-related lymphoedema: results from a population-based, longitudinal breast cancer cohort study","volume":"14","author":"Hayes","year":"2022","journal-title":"Cancers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41523-021-00276-y","article-title":"The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment","volume":"7","author":"J\u00f8rgensen","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12879-023-08839-z","article-title":"Factors associated with cellulitis in lymphoedema of the arm - an international cross-sectional study (LIMPRINT)","volume":"24","author":"Burian","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5535\/arm.2016.40.2.326","article-title":"Prevalence and epidemiological factors involved in cellulitis in korean patients with lymphedema","volume":"40","author":"Park","year":"2016","journal-title":"Ann Rehabil Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2446091","DOI":"10.1001\/jamanetworkopen.2024.46091","article-title":"Financial difficulty over time in young adults with breast cancer","volume":"7","author":"Myers","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12032-024-02421-6","article-title":"Effectiveness of complete decongestive therapy for upper extremity breast cancer-related lymphedema: a review of systematic reviews","volume":"41","author":"Gilchrist","year":"2024","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.7.2225","article-title":"Complete decongestive therapy effect on breast cancer related to lymphedema: A systemic review and meta-analysis of randomized controlled trials","volume":"24","author":"Shamoun","year":"2023","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2022.03.008","article-title":"A review of American insurance coverage and criteria for conservative management of lymphedema","volume":"10","author":"Finkelstein","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102441","article-title":"Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendations","volume":"68","author":"Wong","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01681","article-title":"Prospective surveillance for breast cancer-related arm lymphedema: A systematic review and meta-analysis","volume":"40","author":"Rafn","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/jso.70046","article-title":"Preventing secondary lymphedema: A systematic review and meta-analysis on the efficacy of immediate lymphovenous anastomosis","volume":"132","author":"Hinson","year":"2025","journal-title":"J Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10494-0","article-title":"American society of breast surgeons\u2019 Practice patterns for patients at risk and affected by breast cancer-related lymphedema","volume":"28","author":"DeSnyder","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jso.28067","article-title":"A single institution experience with immediate lymphatic reconstruction: impact of insurance coverage on risk reduction","volume":"131","author":"Huang","year":"2025","journal-title":"J Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e8380","DOI":"10.1371\/journal.pone.0008380","article-title":"Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice","volume":"4","author":"Nakamura","year":"2009","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001278","article-title":"Incidence and risk factors of breast cancer-related lymphedema in Korea: a nationwide retrospective cohort study","volume":"110","author":"Ahn","year":"2024","journal-title":"Int J Surg Lond Engl"},{"key":"B17","unstructured":"JBI Manual for Evidence Synthesis\n          \n          \n            \n              Aromataris\n              E\n            \n            \n              Lockwood\n              C\n            \n            \n              Porritt\n              K\n            \n            \n              Pilla\n              B\n            \n            \n              Jordan\n              Z\n            \n            \n              Alexander\n              L\n            \n          \n          Adelaide, South Australia\n          JBI Global Wiki\n          \n          2024"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B19","unstructured":""},{"key":"B20","unstructured":"Better systematic review management\n          \n          \n          Melbourne, Australia\n          Covidence"},{"key":"B21","unstructured":"Study Quality Assessment Tools\n          \n          \n          Maryland, United States\n          NHLBI, NIH\n          \n          2021"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13070691","article-title":"Commonly prescribed chronic pharmacological medications as risk factors for breast cancer-related lymphedema: an observational retrospective cohort study","volume":"13","author":"Borg","year":"2025","journal-title":"Healthcare"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1457363","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)","volume":"15","author":"Brown","year":"2024","journal-title":"Front Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.15761\/crt.1000293","article-title":"Padera TP.A retrospective analysis of commonly prescribed medications and the risk of developing breast cancer\u2212related lymphedema","volume":"6","author":"Meijer","year":"2020","journal-title":"Clin Res Trials"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4514-5","article-title":"Effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren\u00ae) in addition to complex decongestive therapy on management of breast cancer-related lymphedema","volume":"27","author":"Cacchio","year":"2019","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"B26","unstructured":"Using a twin herbal formula for the treatment of upper limb lymphoedema after breast cancer resection\n          \n          \n            \n              Chiu\n              TW\n            \n          \n          London, United Kingdom\n          Wounds International\n          \n          2024"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2915","DOI":"10.1097\/GOX.0000000000002915","article-title":"Treatment of post-mastectomy lymphedema with herbal medicine: an innovative pilot study","volume":"8","author":"Chiu","year":"2020","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"B28","first-page":"29","article-title":"Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT","volume":"29","author":"Cluzan","year":"1996","journal-title":"Lymphology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/000331979704800115","article-title":"Efficacy of daflon 500 mg in the treatment of lymphedema (Secondary to conventional therapy of breast cancer)","volume":"48","author":"Pecking","year":"1997","journal-title":"Angiology"},{"key":"B30","first-page":"47","article-title":"Efficacy of BN165 (Ginkor Fort) in breast cancer related upper limb lymphedema: a preliminary study","volume":"37","author":"Cluzan","year":"2004","journal-title":"Lymphology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/nu11051021","article-title":"Sodium selenite alleviates breast cancer-related lymphedema independent of antioxidant defense system","volume":"11","author":"Han","year":"2019","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902043400503","article-title":"Lack of effect of coumarin in women with lymphedema after treatment for breast cancer","volume":"340","author":"Loprinzi","year":"1999","journal-title":"N Engl J Med"},{"key":"B33","first-page":"3","article-title":"Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer","volume":"32","author":"Burgos","year":"1999","journal-title":"Lymphology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310143291604","article-title":"Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone","volume":"329","author":"Casley-Smith","year":"1993","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/01635581.2019.1616781","article-title":"The effects of synbiotic supplementation on antioxidant capacity and arm volumes in survivors of breast cancer-related lymphedema","volume":"72","author":"Navaei","year":"2020","journal-title":"Nutr Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.breast.2020.08.008","article-title":"Calorie restriction and synbiotics effect on quality of life and edema reduction in breast cancer-related lymphedema, a clinical trial","volume":"54","author":"Vafa","year":"2020","journal-title":"Breast"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/biology10090934","article-title":"Pilot study of anti-th2 immunotherapy for the treatment of breast cancer-related upper extremity lymphedema","volume":"10","author":"Mehrara","year":"2021","journal-title":"Biology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1028926","article-title":"Doxycycline for the treatment of breast cancer-related lymphedema","volume":"13","author":"Brown","year":"2022","journal-title":"Front Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2022.08.011","article-title":"Phase 1 lymfactin\u00ae Study: 24-month efficacy and safety results of combined adenoviral VEGF-C and lymph node transfer treatment for upper extremity lymphedema","volume":"75","author":"Lepp\u00e4puska","year":"2022","journal-title":"J Plast Reconstr Aesthetic Surg JPRAS"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000011675","article-title":"Phase II study shows the effect of adenoviral vascular endothelial growth factor C and lymph node transfer in lymphedema","volume":"155","author":"Rannikko","year":"2025","journal-title":"Plast Reconstr Surg"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4733.18.07667-8","article-title":"Supplementation with Robuvit\u00ae in post-mastectomy post-radiation arm lymphedema","volume":"73","author":"Belcaro","year":"2018","journal-title":"Minerva Chir"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.23736\/S1593-232X.18.00421-6","article-title":"Pilot study using bioimpedance to evaluate the treatment of arm lymphedema using diosmin and micronized hesperidin","volume":"19","author":"De Godoy","year":"2018","journal-title":"Acta Phlebol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2109","article-title":"Effect of home-based exercise and weight loss programs on breast cancer-related lymphedema outcomes among overweight breast cancer survivors: the WISER survivor randomized clinical trial","volume":"5","author":"Schmitz","year":"2019","journal-title":"JAMA Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073907","article-title":"The role of inflammation in lymphedema: A narrative review of pathogenesis and opportunities for therapeutic intervention","volume":"25","author":"Bowman","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.46883\/2025.25921046","article-title":"GLP-1 receptor agonist use and weight change in patients with breast cancer","author":"Shen","year":"2025","journal-title":"Oncol Williston Park N"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167744","article-title":"GLP-1 receptor agonists in breast cancer: A new frontier in obesity and prognosis management","volume":"26","author":"Xande","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B47","unstructured":"First-of-its-kind Breast Cancer Research Study Explores the Impact of Weight Loss Drugs on Recurrence\n          \n          \n          Texas, United States\n          Bayl Scott White Health\n          \n          2024"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e165324","DOI":"10.1172\/jci.insight.165324","article-title":"PPAR\u03b3 agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFR\u03b1+ mesenchymal cells","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e123775","DOI":"10.1172\/jci.insight.123775","article-title":"Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema","volume":"3","author":"Rockson","year":"2018","journal-title":"JCI Insight"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s13770-025-00728-7","article-title":"Synergistic effect of stromal vascular fraction and lymph node transfer in a rabbit hindlimb model","volume":"22","author":"Lee","year":"2025","journal-title":"Tissue Eng Regener Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-023-06947-7","article-title":"Advances in the prevention and treatment of breast cancer-related lymphedema","volume":"200","author":"Donahue","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05521-x","article-title":"Resistance exercise and breast cancer\u2013related lymphedema\u2014a systematic review update and meta-analysis","volume":"28","author":"Hasenoehrl","year":"2020","journal-title":"Support Care Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1751628\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:40:51Z","timestamp":1772602851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1751628\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":52,"alternative-id":["10.3389\/fonc.2026.1751628"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1751628","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1751628"}}